|
|
||||||||
Original Article |
From 1990 to 2001, numerous site- and phosphorylation state-specific antibodies have been developed and many are now commercially available. These antibodies have facilitated understanding of the cytoskeletal organization, signal transduction and transcriptional mechanisms as well as clinical diseases. This review is an attempt to cover all these aspects.
This article has been cited by other articles:
![]() |
Y. P. Lim Mining the Tumor Phosphoproteome for Cancer Markers Clin. Cancer Res., May 1, 2005; 11(9): 3163 - 3169. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Sheffield and J. J. Gavinski Proteomics Methods for Probing Molecular Mechanisms in Signal Transduction J Dairy Sci, July 1, 2003; 86(13_suppl): E115 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Sheffield and J. J. Gavinski Proteomics methods for probing molecular mechanisms in signal transduction J Anim Sci, March 1, 2003; 81(suppl_3): 48 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-O. Ku, S. Michie, E. Z. Resurreccion, R. L. Broome, and M. B. Omary Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression PNAS, April 2, 2002; 99(7): 4373 - 4378. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-O. Ku, S. Michie, E. Z. Resurreccion, R. L. Broome, and M. B. Omary Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression PNAS, April 2, 2002; 99(7): 4373 - 4378. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |